Compare CIM & AORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CIM | AORT |
|---|---|---|
| Founded | 2007 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 2.1B |
| IPO Year | 2007 | 1993 |
| Metric | CIM | AORT |
|---|---|---|
| Price | $12.71 | $44.62 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 5 |
| Target Price | $15.25 | ★ $49.36 |
| AVG Volume (30 Days) | ★ 799.9K | 345.5K |
| Earning Date | 02-11-2026 | 11-06-2025 |
| Dividend Yield | ★ 11.91% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $191,573,000.00 | ★ $422,646,000.00 |
| Revenue This Year | $11.44 | $15.97 |
| Revenue Next Year | $21.50 | $10.96 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 9.81 |
| 52 Week Low | $9.85 | $21.97 |
| 52 Week High | $15.37 | $48.25 |
| Indicator | CIM | AORT |
|---|---|---|
| Relative Strength Index (RSI) | 49.41 | 40.08 |
| Support Level | $12.30 | $45.75 |
| Resistance Level | $12.96 | $48.00 |
| Average True Range (ATR) | 0.23 | 1.36 |
| MACD | -0.03 | -0.20 |
| Stochastic Oscillator | 50.87 | 9.43 |
Chimera Investment Corporation is a real estate investment trust engaged in investing in a portfolio of mortgage assets on a leveraged basis. These investments include a variety of government-sponsored agency residential mortgage-backed securities, or RMBS, non-agency RMBS, agency commercial mortgage-backed securities, residential mortgage loans, and other real estate-related securities. Agency mortgage-backed securities represent the share of this portfolio, while subprime residential mortgage loans and non-agency RMBS also make up substantial shares.
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.